Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China
· Delayed Price · Currency is CNY 157.62
+0.50 (0.32%)
Mar 10, 2026, 10:04 AM CST
SHA:600436 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 94,793 | 129,412 | 145,997 | 174,033 | 263,740 | 161,393 | Upgrade
|
| Market Cap Growth | -23.73% | -11.36% | -16.11% | -34.01% | 63.41% | 146.34% | Upgrade
|
| Enterprise Value | 95,074 | 127,896 | 144,884 | 173,032 | 258,268 | 157,158 | Upgrade
|
| Last Close Price | 157.12 | 211.08 | 234.62 | 278.46 | 420.42 | 256.73 | Upgrade
|
| PE Ratio | 39.19 | 43.47 | 52.19 | 70.39 | 108.45 | 96.56 | Upgrade
|
| Forward PE | 32.26 | 37.47 | 42.87 | 70.44 | 94.42 | 87.42 | Upgrade
|
| PS Ratio | 9.69 | 12.00 | 14.52 | 20.02 | 32.88 | 24.79 | Upgrade
|
| PB Ratio | 6.30 | 8.72 | 10.49 | 14.72 | 26.02 | 19.55 | Upgrade
|
| P/TBV Ratio | 6.67 | 9.24 | 11.16 | 15.81 | 27.81 | 21.23 | Upgrade
|
| P/FCF Ratio | - | 527.32 | 70.71 | 25.98 | 712.61 | 153.99 | Upgrade
|
| P/OCF Ratio | 189.00 | 98.51 | 66.16 | 25.32 | 570.53 | 110.01 | Upgrade
|
| PEG Ratio | - | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | Upgrade
|
| EV/Sales Ratio | 9.72 | 11.86 | 14.40 | 19.90 | 32.20 | 24.14 | Upgrade
|
| EV/EBITDA Ratio | 37.19 | 36.81 | 43.93 | 59.73 | 90.50 | 83.51 | Upgrade
|
| EV/EBIT Ratio | 38.47 | 37.40 | 44.86 | 60.73 | 94.00 | 87.72 | Upgrade
|
| EV/FCF Ratio | -134.91 | 521.14 | 70.17 | 25.84 | 697.82 | 149.95 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 0.41 | 0.33 | 0.35 | 0.38 | 0.31 | 0.38 | Upgrade
|
| Debt / FCF Ratio | - | 4.68 | 0.56 | 0.17 | 2.39 | 0.69 | Upgrade
|
| Net Debt / Equity Ratio | -0.02 | -0.26 | -0.65 | -0.64 | -0.61 | -0.54 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.11 | -1.11 | -2.73 | -2.62 | -2.18 | -2.37 | Upgrade
|
| Net Debt / FCF Ratio | 0.41 | -15.72 | -4.36 | -1.13 | -16.81 | -4.25 | Upgrade
|
| Asset Turnover | 0.55 | 0.62 | 0.64 | 0.64 | 0.71 | 0.69 | Upgrade
|
| Inventory Turnover | 1.14 | 1.48 | 1.79 | 1.87 | 1.72 | 1.67 | Upgrade
|
| Quick Ratio | 1.15 | 2.52 | 3.91 | 3.85 | 3.70 | 3.23 | Upgrade
|
| Current Ratio | 5.00 | 4.77 | 5.24 | 5.06 | 4.98 | 4.61 | Upgrade
|
| Return on Equity (ROE) | 16.27% | 20.83% | 22.15% | 22.98% | 26.80% | 22.19% | Upgrade
|
| Return on Assets (ROA) | 8.71% | 12.35% | 12.74% | 13.13% | 15.11% | 11.78% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.17% | 36.43% | 59.76% | 59.24% | 61.13% | 42.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.10% | 22.50% | 22.80% | 23.60% | 26.50% | 21.30% | Upgrade
|
| Earnings Yield | 2.55% | 2.30% | 1.92% | 1.42% | 0.92% | 1.04% | Upgrade
|
| FCF Yield | -0.74% | 0.19% | 1.41% | 3.85% | 0.14% | 0.65% | Upgrade
|
| Dividend Yield | 2.03% | 1.41% | 0.99% | 0.45% | 0.29% | 0.35% | Upgrade
|
| Payout Ratio | 110.09% | 71.46% | 28.05% | 30.77% | 23.41% | 31.25% | Upgrade
|
| Buyback Yield / Dilution | 0.04% | -0.16% | 0.02% | 0.07% | -0.00% | -0.11% | Upgrade
|
| Total Shareholder Return | 2.07% | 1.24% | 1.01% | 0.52% | 0.29% | 0.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.